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Risk assessment approaches increasingly use
two complementary concepts—mode of
action and tissue dose—to organize available
toxicological and epidemiological studies, to
decide on the shape of the dose–response
curve (linear, nonlinear, or threshold), and
to conduct low-dose, interspecies, dose
route, and interindividual extrapolations
(Andersen and Dennison 2001). Mode of
action provides a basis to decide qualita-
tively on the shape of the dose–response
curve (U.S. EPA 1999). By knowing the
nature of tissue dose, i.e., whether it is par-
ent chemical, metabolite, receptor-bound
toxicant, etc., physiologically based phar-
macokinetic (PBPK) models can be used to
calculate tissue dose metrics for various
dose routes, species, and dose levels to sup-
port extrapolations (Clewell and Andersen
1985). These two organizing principles,
mode of action and tissue dosimetry, have
the potential to encourage application of a
wide array of mechanistic data and biologi-
cally based modeling in chemical risk
assessment. However, for nonlinear and
threshold responses, acceptable exposure
limits are still primarily derived by a proce-
dure based on objective evaluation of
dose–response curves, followed by applica-
tion of multiple uncertainty factors that
adjust for interspecies differences in
response, for interindividual response dif-
ferences in humans, for adequacy of avail-
able data, and to adjust to lifetime exposure
periods. Many of these uncertainty factors
are used because of ignorance about the
shape of dose–response curves at low inci-
dence levels for these responses. 
A variety of toxicants interfere with cel-
lular signaling by endogenous endocrine sys-
tem hormones and biological receptors
(Kavlock and Ankley 1996). Our under-
standing of these signaling pathways, at least
qualitatively, has increased markedly in
recent years through new techniques in mol-
ecular biology, including studies using
knockout and transgenic animals and the
development of high throughput methods
in genomics, transcriptomics, and pro-
teomics. Some major signaling motifs that
are of interest for toxic responses include
actions of nuclear receptors, such as mem-
bers of the steroid hormone family receptors
(Landers and Spelsberg 1992), and G-pro-
tein–coupled cell-surface receptors, such as
those proteins that recognize peptide-stimu-
lating hormones secreted by the anterior
hypothalamus (Clement et al. 2001). A pos-
sible impediment to the quantitative appli-
cation of these data in risk assessment is the
sheer volume of the information being col-
lected at different levels of biological detail,
i.e., the molecular, cellular, organ system,
organism, and population levels. How will
we order and make sense of all this informa-
tion to provide a more complete under-
standing of dose–response curves for
endogenous signaling components and for
exogenous compounds that interfere with
these signaling motifs?
Noble recently emphasized the com-
plementary roles of observation and
computational modeling in studying the
physiological function of biological systems.
He writes:
The amount of biological data generated over
the past decade by new technologies has com-
pletely overwhelmed our ability to understand it
. . . Indeed, it is hard to see how [the] unraveling
of complex physiological processes can occur
without the iterative interaction between experi-
ment and simulation . . . In a few years’ time we
shall all wonder how we ever managed to do
without [computational models]. . . . (Noble
2002).
These same comments apply to the
generation of information on mode of
action in chemical risk assessment. Studies
on mode of action are essentially qualita-
tive in nature and must be organized by
quantitative computational models to
make predictions of the shape of the
dose–response curves and to suggest
important new experimentation. In risk
assessment these computational models
are referred to as biologically based
dose–response (BBDR) models and pro-
vide the substrate for simulations that link
mode of action research with predicted
physiological consequences of exposures
(Setzer et al. 2001). Here we discuss risk
assessment approaches for nonlinear toxi-
cological processes that take into account
dose–response behaviors of native signal-
ing molecules required for normal func-
tion, perturbations of these systems by the
presence of toxicants, and BBDR model-
ing of the underlying molecular circuitry
associated with normal and impaired func-
tion of these signaling motifs. 
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Signaling motifs (nuclear transcriptional receptors, kinase/phosphatase cascades, G-coupled pro-
tein receptors, etc.) have composite dose–response behaviors in relation to concentrations of pro-
tein receptors and endogenous signaling molecules. “Molecular circuits” include the biological
components and their interactions that comprise the workings of these signaling motifs. Many of
these molecular circuits have nonlinear dose–response behaviors for endogenous ligands and for
exogenous toxicants, acting as switches with “all-or-none” responses over a narrow range of con-
centration. In turn, these biological switches regulate large-scale cellular processes, e.g., commit-
ment to cell division, cell differentiation, and phenotypic alterations. Biologically based
dose–response (BBDR) models accounting for these biological switches would improve risk
assessment for many nonlinear processes in toxicology. These BBDR models must account for
normal control of the signaling motifs and for perturbations by toxic compounds. We describe
several of these biological switches, current tools available for constructing BBDR models of
these processes, and the potential value of these models in risk assessment. Key words: biological
switches, dose–response relationships, endocrine-active compounds, estrogen, molecular
circuitry, pharmacodynamic models, risk assessment, TCDD. Environ Health Perspect 110(suppl
6):971–978 (2002).
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Perturbations of Signaling
Pathways
Molecular Circuitry
Gene and protein arrays, simultaneously
assaying the expression of hundreds or thou-
sands of genes and proteins, provide infor-
mation on expression of suites of genes and
batteries of protein products that are coordi-
nately regulated and the manner in which
toxicants alter their expression. However,
the data from these arrays must be inte-
grated to provide an understanding of bio-
logical function rather than serving simply
as a catalog of change. Lander and
Weinberg have expressed their opinion
regarding the overall goal of genomics: 
The long-term goal is to use this information to
reconstruct the complex molecular circuitry that
operates within the cell to map out the network
of interacting proteins that determines the
underlying logic of various cellular biological
functions including cell proliferation, responses
to physiologic stresses, and acquisition and
maintenance of tissue-specific differentiation
functions. A longer term goal, whose feasibility
remains unclear, is to create mathematical mod-
els of these biological circuits and thereby pre-
dict these various types of cell biological
behavior. (Lander and Weinberg 2000)
The underlying concept here is that
biological functions require the successful
operation of speciﬁc circuits that coordinate
information ﬂow and govern cellular behav-
ior under a variety of physiological condi-
tions. Analogous to electric circuits,
molecular circuits consist of components
(proteins, RNAs, signaling molecules, etc.,
and cellular targets) that organize flows of
cellular information, although there is
arguably more variability in the biological
than in the electrical system. Toxicants,
especially those that interfere with hor-
mones and signaling motifs, can interfere
with normal functioning of these molecular
circuits, leading to altered function and
ultimately to toxicity. 
Biological Switches
Molecular circuits are controlled by energy
provided in the form of receptors and lig-
ands that activate signaling motifs, leading to
downstream biological consequences. Most
responses to these signaling compounds are
themselves nonlinear. The process by which
some endogenous ligands or toxicant com-
pounds cause nonlinear responses is referred
to here as “switching.” Switches activate fun-
damental changes in functional behaviors of
cells in an all-or-none fashion. The more
nonlinear the response is, the more switch-
like it is. Switches are another functional
component of circuits. Signaling motifs with
linear dose–response behavior would be
expected to show graded responses to
changes in signal concentration. However,
very few examples of graded transcriptional
response have been reported for eukaryotic
gene expression (Louis and Becskei 2002).
The carefully timed development of organ-
isms from a single fertilized cell requires
coordination of a series of cellular switches
to complete the transformation from a single
fertilized cell to a mature organism
(Davidson et al. 2002).
Several nonlinear switching processes
have been examined quantitatively.
Progesterone induces maturation of Xenopus
oocytes. The dose response for maturation
of individual oocytes was described with a
Hill equation for the activation of mitogen-
activated protein kinase (MAPK) (Ferrell
and Machleder 1998):
[1]
where C is concentration of progesterone
and K d
n is the concentration at half-maximal
response. In the Hill equation the exponent
n (Hill coefﬁcient) determines the steepness
of the dose–response curve. In simpler mol-
ecular systems such as dimerization of estro-
gen receptors, an n value of 2.0 for a
functional response such as gene expression
may simply indicate involvement of a
bimolecular process. With oxygen binding
to hemoglobin, n values of 3–4 indicate that
binding of the first oxygen molecule to the
hemoglobin tetramer leads to structural
changes, facilitating binding to the remain-
ing three sites (allosteric binding). With
Xenopus oocyte maturation, Hill coefﬁcients
for individual oocytes were reported to be
between 20 and 30 (Ferrell and Machleder
1998). These high values indicate an all-or-
none switch for maturation in any individ-
ual oocyte. For populations of oocytes the
progesterone concentrations causing matu-
ration were distributed fairly broadly.
Evaluation of populations of oocytes did
not show the all-or-none responses noted in
individual cells. In the oocyte, progesterone
receptor and MAPK cascade-signaling
motifs combine to control a switch that ini-
tiates maturation circuitry. 
Receptor upregulation may also produce
nonlinear biological responses. Certain bac-
teria change phenotypic characteristics
under conditions that encourage bacterial
growth. As bacterial concentrations increase,
secondary metabolites are released into the
surrounding media. As the concentration of
this signaling molecule increases, the
metabolite, in concert with a cytosolic
receptor, initiates transcription of a set of
genes leading to new phenotypic character-
istics in the bacteria. Photobacterium ﬁschreii
regulates genes that control phosphores-
cence via this mechanism (Fuqua et al.
1994). The suites of genes controlled by the
secondary metabolite–receptor interaction
include the receptor protein itself and an
enzyme that converts the secondary metabo-
lite to a higher-affinity ligand. Thus, these
metabolites indirectly serve as surrogates for
the concentration of bacteria. Because of the
relationship to bacterial number, these
responses are called “quorum sensing.” The
metabolite accumulation signals the bacteria
that they are present in sufficient quantity
to change phenotypic characteristics. Many
bacteria, including film formation in some
species (Costerton et al. 1995; Davies et al.
1998), use quorum-sensing motifs to
respond to environmental stimuli. Efforts to
model these biological processes are also
under way (Koerber et al. 2002).
Estrogen receptor upregulation controls
vitellogenesis in some fish, leading to non-
linear dose–response relationships and stable
differentiation of hepatocytes treated with
high doses of estrogenic compounds
(Shapiro et al. 1989). The possible role of
receptor upregulation in these nonlinear
responses was investigated by simulation
with a pharmacodynamic gene induction
model. Several generic gene induction mod-
els were developed and exercised (Andersen
and Barton 1999). These models recapitu-
lated nonlinear behaviors with very high
Hill coefﬁcients. More recently a transcrip-
tional switch controlling methylation of
nucleosomes and transcriptional cofactors
was described (Xu et al. 2001) that was asso-
ciated with coactivator-associated arginine
methyltransferase-1 (CARM-1). This mole-
cule acts as a coactivator for nuclear hor-
mone signaling via histone methylation and
as a co-repressor of cyclic-AMP–associated
signaling pathways. This switch involves
limiting concentrations of the CARM-1
coactivator and acts via histone modiﬁcation
to increase access to speciﬁc genes and pro-
moter regions. Activation of transcription
by the nuclear receptors, in concert with
CARM-1, is expected to activate groups of
genes and to silence others.
The proper function of all these signaling
pathways requires correct concentrations of a
variety of endogenous proteins and signaling
molecules. To a very large extent, dose
response, a concept used frequently in toxicol-
ogy in regard to adverse responses, now has an
equally important position in normal biology.
The ideas expressed in this regard are proper
gene dosages in cells, leading to proper con-
centrations of receptors and ligands for nor-
mal function. The proper functioning of
molecular circuits and maintenance of healthy
conditions in the organism requires appropri-
ate doses of various signaling components and
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their presence at appropriate times for activa-
tion of biological switches. 
Endocrine-Active Compounds
Many endocrine-active compounds (EACs)
interact with the normal cell circuitry to
mimic or antagonize the actions and functions
of normal signaling systems. Excess of EACs
or deﬁciencies of natural hormones alter hor-
monal system function, leading to impaired
health. Impaired health covers a wide range of
responses, including loss of viability, impaired
performance, altered reproductive success, and
delayed maturation. The actions of many sig-
naling elements—cell-surface receptors,
cytosolic transcriptional factors, kinase/phos-
phatase cascades—are now more completely
understood than just a few years ago. Studies
of the toxic responses to EACs need to begin
with examination of normal function of these
signaling motifs and how the normal function
becomes perturbed by exogenous compounds
(Figure 1). The ﬁrst requirement in a BBDR
model, then, is to develop an adequate repre-
sentation for the dose–response control of nor-
mal function. Secondarily, the focus is on the
perturbation of normal function by exogenous
compounds. This reorientation to a perturba-
tion approach to normal biology rather than
an emphasis on final pathology provides
new avenues and strategies to evaluate
dose–response relationships in biology and in
toxicology. These EACs serve as examples
through the remainder of this article.
BBDR Models for Molecular
Circuits and Switches
Concerted Cellular Responses
Most dose–response assessment models in
toxicology assume smooth, continuous
changes in response to dose. These models
describe many chemical processes by statisti-
cal methods with average behaviors of mole-
cules, as the numbers of particles involved
in most reactions and interactions are very
large. The real world of cells demonstrates a
more complex variety of interacting cir-
cuitry. At the cellular level, behaviors are
more likely to be nonlinear and stochastic.
A cell either divides or it does not divide. In
moving from one phenotypic state to
another, all the components have to change
in concert to achieve a smooth pleiotropic
alteration in cell characteristics. A challenge
in formulating the mathematical models of
cellular functions is the requirement to
grasp the manner in which continuous
changes of chemical variables (i.e., ligand
and receptor concentrations) lead to sto-
chastic responses such as apoptosis, prolifer-
ation, differentiation, or activation of global
cellular circuitry by exposure to chemicals. 
Stochastic, nonlinear models of cellular-
level responses may provide the basis for
developing tools that will simulate nonlinear
dose–response behaviors toward toxic expo-
sures. Some stochastic models assess cancer
risks based on rates of cell division, cell
death, and cell mutation. The Moolgavkar-
Venzon-Knudson (MVK) model (Figure 2)
represents a stochastic model of carcinogen-
esis (Moolgavkar and Knudson 1981).
These cancer models have to be initially set
to describe tumor incidence in the control
animals. These background rates are then
altered, i.e., perturbed by the actions of tox-
icant compounds. In developing BBDR
models it is necessary to evaluate the effect
of dose on intrinsic biological parameters of
the model. The effects can be described
empirically, as has usually been done, or
mechanistically. For the cancer models the
stochastic aspect involves some probability
of division, death, or mutation that occurs
randomly. Mechanistically, the requirement
is to understand (model) the relationship of
these probabilities with dose and to
describe the manner in which dose changes
the probability of division, death, or muta-
tion during a time interval. The relation-
ships between dose and cell proliferation or
between dose and cell apoptosis are unlikely
to be simple continuous functions. The
control of biological circuitry and the tran-
sition between different states of the cellu-
lar circuitry in response to exogenous
signaling molecules should determine the
dose–response manifestations for prolifera-
tion, apoptosis, and mutation in many of
these cancer models. 
Receptor-Mediated Control 
of Gene Products
Many EACs directly or indirectly interfere
with gene expression. In discussing molec-
ular circuits the changes are generally coor-
dinate alterations in groups of genes that
lead to altered biological characteristics of
the affected cells. It is often possible to
measure responses of single genes with
great precision using modern techniques
such as polymerase chain reaction amplifi-
cation of gene transcripts. Molecular mark-
ers, such as induction of cytochrome
P4501A1 (CYP1A1) message by 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD)
(Vanden Heuvel et al. 1994), allows obser-
vation of the dose–response curves in lower
dose ranges than possible when examining
overt adverse responses of the organism.
However, these measurements lead to
questions about the linkage between these
precursor effects and clearly adverse
responses of the organism. For instance,
should the observation of a 1% increase in
CYP1A1 mRNA after 2,3,7,8-TCDD
treatment be considered adverse? This
focus on a single gene may not be the cor-
rect one for assessing toxicity. Dioxin and
similar receptor-mediated EACs do not
simply control expression of a single gene
in the intact liver. They alter concentra-
tions of a battery of gene products to
induce a concerted, pleiotropic response in
hepatocytes (Bock 1993). 
An Example with Tumor Promotion
Dioxin is a liver carcinogen in rats and a
tumor promoter (Kociba et al. 1978; Pitot
et al. 1987). Many liver tumor promoters
act by transiently increasing proliferation of
hepatocytes with longer-term adaptation to
the exposures. The adaptation, with pheno-
barbital, involves elaboration of transform-
ing growth factor-β, a specific growth
factor that constrains hepatocyte prolifera-
tion (Jirtle et al. 1991). Cells resistant to
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Figure 1. Dose–response models for perturbations
of signaling motifs focus on normal biology includ-
ing dose–response behavior for endogenous sig-
naling molecules and cognate receptors. The
actions of EACs would appear as perturbations on
the normal, nonlinear control of molecular circuitry
and the switching modules moving between and
among various circuits. 
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Figure 2. The MVK model for cancer, including cell
division, cell death, and probabilities of mutation
during replication. Although the model itself is sto-
chastic, the biological processes represented by
birth and death may themselves represent toxicant
actions on nonlinear signaling motifs associated
with perturbation of cellular circuits by the pres-
ence of toxicants. N represents the population of
normal cells, I the initiated cells, and M the
mutated cells. The parameter α represents the cell
birth rate, β the cell death rate, and µ the transfor-
mation rate, where subscript 1 refers to the normal
population and 2 refers to the initiated population.cytoinhibition are presumed to derive a
growth advantage and grow out to preneo-
plastic foci under the selection pressure
from the promoter. The dose–response
relationship for carcinogenesis requires
characterization of the dose of promoter
required to increase the proliferation of
hepatocytes. 
Phenobarbital, in common with a large
number of liver tumor promoters, has a
receptor-mediated mode of action. These
promoters interact with protein receptors
that serve as transcriptional modulators to
alter expression of batteries of genes in the
hepatocytes. Phenobarbital interacts via the
constitutive androstane receptor (Waxman
1999). Other liver tumor promoters act via
the aryl hydrocarbon receptor (AhR)
(Wilson and Safe 1998), the peroxisome
proliferation–activating receptor (Weghorst
et al. 1994), or the pregnane-X receptor
(Waxman 1999). All these receptors, in
concert with the toxic compounds, act to
increase expression of batteries of genes,
leading to several alterations in expression of
many individual gene products, including
speciﬁc genes. The effects on cell-level char-
acteristics are likely to be associated with
these pleiotropic responses.
Among these promoters, 2,3,7,8-TCDD
has received a great deal of attention in the
past decade as the U.S. Environmental
Protection Agency has reevaluated the risks
of exposure to this environmental contami-
nant (U.S. EPA 2000). PBPK and protein
induction models describe dioxin kinetics in
the body, including binding to the AhR
with activation of specific gene products
(Kohn et al. 1993; Leung et al. 1990).
These models have also described the induc-
tion of speciﬁc genes through interactions of
the AhR–TCDD complex with DNA-
response elements for the AhR and various
partnering molecules (Andersen et al.
1997b. Like most mathematical models of
biological systems, the BBDR models
presently available for dioxin represent a sig-
nificant simplification of the individual
molecular processes. Simpliﬁcations are nec-
essary to attain a computationally tractable
model and may be useful to gain insights
about dose–response behavior (Suk and
Yang 2002). Bailey has emphasized the
value and necessity of using simplifications
in modeling complex, biological systems
(Bailey 2001). However, it is important that
the simpliﬁcations retain the important bio-
logical aspects of the responses. 
The regulation of gene expression by
dioxin and dioxinlike polychlorinated
biphenyls (PCBs) and the AhR has been
investigated in a variety of systems, includ-
ing many cell constructs with the CYP1A1
promoter upstream of particular marker
genes (Garrison et al. 2000; Jeon and Esser
2000). Such constructs allow evaluation of
the components necessary to control gene
expression by the AhR in a system with an
available promoter. However, in the intact
animal, the silencing or activation of
genomic structures that are not present in
the cell constructs may alter gene expres-
sion. We are studying AhR-mediated induc-
tion of CYP1A1 in primary hepatocytes.
Induction does not follow coherent
dose–response relationships expected for a
Hill relationship with a low n value. This
behavior is true both in vivo (Chubb et al.
2002) and in vitro in the primary hepato-
cytes (French et al. 2002), as shown in
Figures 3 and 4, respectively. 
With AhR agonists, the response of cells
in the liver and of cells in vitro does not
appear to follow a continuous response pat-
tern where a 50% induction in the total liver
is reﬂected by a 50% induction in all hepa-
tocytes. The induction of individual cells
appears to occur almost in an all-or-none
fashion. Cells are either induced or remain
in a basal state (Andersen et al. 1997a;
Tritscher et al. 1992). This response, a con-
certed response of a cell to the receptor–lig-
and complex, is not yet well understood.
The molecular circuitry that causes this
switchlike behavior leads to a qualitative
alteration in response over a narrow range of
dose, moving the cell from one state to a
new one. In the liver different acinar regions
have varying sensitivity for induction. At low
doses centrilobular cells are induced. As dose
increases, more of the cells in the liver
become induced and the region of induced
cells progresses toward the periportal area of
the liver acinus (Figure 3). Andersen et al.
modeled regional enzyme induction using a
semiempirical induction model (Andersen 
et al. 1997a) that could represent the differen-
tial induction throughout the liver (Figure 5).
This regional induction model coupled a
PBPK model for the disposition of dioxin in
the body, a geometric representation of the
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0.1 µg/kg PCB 126
10 µg/kg PCB 126
0.1 µg/kg PCB 126 + 10 µg/kg PCB 153 1.0 µg/kg PCB 126 + 100 µg/kg PCB 153
10 µg/kg PCB 126 + 1,000 µg/kg PCB 153 10 µg/kg PCB 126 + 10,000 µg/kg PCB 153
Corn oil control
Figure 3. Induction of CYP1A1 and 1A2 by PCB 126 (3,4,5-3´,4´-pentachlorobiphenyl) in rat liver and the inﬂuence of a second promoter. (A) The pattern of immuno-
histochemical staining for CYP1A1 protein is consistent with a switch that induces a change from a normal phenotype to an AhR-responding phenotype over a
narrow range of dose. In the context of the topic of this article, this AhR-agonist PCB has altered the molecular circuitry of these hepatocytes, leading to activa-
tion of a cellular switch. (B) In the presence of high daily doses of PCB 153, a phenobarbital-like enzyme inducer that increases concentrations of a different
cytochrome (CYP2B1/2), PCB 126 no longer induces cells in the centrilobular region of the liver. The presence of high PCB 153 (10,000 µg/kg) has turned off the
AhR switch (Chubb et al. 2002).liver acinus, and a more empiricalal descrip-
tion of enzyme induction. Enzyme induc-
tion in each zone of the liver acini was
modeled with a Hill-type equation, with
variable affinities for AhR–ligand–DNA
interactions in each acinar region. Successful
modeling of induction in a five-compart-
ment liver acinus required that binding
afﬁnities differ by a factor of three between
adjacent acinar regions, with high Hill coef-
ficients for induction (i.e., 4–5) in each
region of the acinus. The next step will be to
provide a more mechanistic description of
the molecular circuit and switching that
comprises this all-or-none behavior. 
These switching responses of hepato-
cytes appear to represent a reversible differ-
entiation to a new stable state (a new
phenotype) of the hepatocyte. This differen-
tiation includes the concerted induction of a
battery of genes. Interestingly, the current
induction models (Andersen et al. 1997b;
Kohn et al. 1993), if extended to describe
multiple genes with independent promoters,
would give rise to competitive, not coopera-
tive, interactions. Biological mechanisms
that might explain nonlinear, concerted
responses of gene batteries include receptor
autoregulation, genomic level switches, such
as that noted for histone methylation, or
kinase cascades. We are now developing an
experimental system to study responses of
isolated hepatocytes to dioxinlike com-
pounds (French et al. 2002). This experi-
mental system is intended to permit
evaluation of the mechanistic characteristics
of the hepatocyte switch, including the role
of kinase cascades or histone modification,
in these processes. The accumulation of
more mechanistic data on induction is nec-
essary to provide sufficient biological detail
to predict low-dose behavior.
Discussion 
Modeling Tools for Describing
Biological Switches
Chaos and attractors. Our continuing eval-
uation of induction responses of hepatocytes
has led us to a set of new concepts for future
exposure dose–response assessments. They
include biological switching, molecular cir-
cuits, and multiple stable states of the cells,
in addition to our old concerns regarding
the relationship of molecular-level responses
and the ultimate expression of toxicity.
How will we model these responses to pre-
dict responses over a wide range of dose
based on biological characteristics of cellular
switches? Chaos and complexity theorists
have discussed concepts of stable attractors
in complex systems. In the context of mole-
cular biology, an attractor is the proteomic
state of the cell (including the antecedent
genomic state) that is stable because of its
ability to maintain homeostasis within a
range of conditions. The attractor concept
implies that there are a ﬁnite number of sta-
ble states that exist rather than a smooth
transition between infinite numbers of cell
phenotypes. In particular, these concepts
suggest that mammalian cells may exist in a
suite of differentiated forms that represent
stable attractors for the overall behavior of
the genetic content of the cell (Kaufman
1995). Shapiro and colleagues (1989) and
Simon et al. (1988) have pursued limited
modeling of stable states for hormone
responsiveness of cells for estrogen-respon-
sive actions. The basal or induced states in
hepatocytes caused by tumor promoters
may represent two stable attractors. The
increasing concentration of the receptor–lig-
and complex may alter the concentration of
a limited set of initial gene products that
move the circuitry from that for one stable
attractor to a second stable attractor. Over
time, the overall content and behavior
change, consistent with the new stable state.
The new state determines the pathological
or physiological consequences of induction
for the cell, whereas the dose response of the
process is more likely determined by some
of the early interactions of the ligand and
the receptor molecules in the most sensitive
population of cells. Tyson et al. (2001) have
used similar cellular paradigms to describe
the cell cycle.
Early (transient) and late (persistent)
responses to signaling molecules. Switches are
likely to be organized by positive feedback
circuits to drive transitions from one state to
another. In normal maintenance of cell func-
tion in a given state, homeostatic responses
are more generally associated with negative
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Figure 4. CYP1A1 staining in vitro. Immunohistochemical staining for CYP1A1 in rat primary hepatocytes
treated with various concentrations of PCB 126 for 24 hr. The staining occurs in increasing numbers of
cells with increasing dose rather than increasing concentrations of protein in each cell proportional to
dose (French et al. 2002).
Figure 5. The predicted staining pattern for dioxin
induction of CYP1A1 in rat liver at various doses of
dioxin. A PBPK model was linked to a nonlinear,
semiempirical model of gene induction to examine
the degree of nonlinearity indicated by the regional
induction data with various daily doses of dioxin,
as observed by Tritscher et al. (1992). The regional
Hill coefficient for protein induction required to
provide demarcation between adjacent regions of
the liver, 4–5, indicated a switch controlling differ-
ent phenotypic behaviors of the hepatocytes.
Reproduced from Andersen et al. (1997a) with per-
mission from Academic Press.feedback, as with the feedback processes for
endocrine target-organ function and release
of stimulating hormones from the pituitary.
One concept involved in steroid hormone
function (Landers and Spelsberg 1992) and
in memory storage was the involvement of
early and late responses organized by tran-
scriptional receptor or nervous system activa-
tion of cells (Kandel 2001). Here, early
responses are more transient; however, if
these signals persist or are of sufﬁcient mag-
nitude, they initiate more permanent alter-
ations of genetic expression of gene batteries
and alterations of cell characteristics. 
Some possible experimental and compu-
tational models. Among a wider range of
possibilities, it is apparent that nonlinear
switching modules exist for receptor
autoregulation (Shapiro, et al. 1989),
kinase/phosphatase cascades (Ferrell and
Machleder 1998), and Ca2+-mediated
nerve-cell signaling related to long-term
potentiation (Bhalla and Iyengar 1999).
Although the nonlinear characteristics of
these switches are evident, none have been
examined in sufficient detail to provide a
quantitative understanding of the molecular
basis of the switch and its influence on the
dose–response curve at low incidence levels.
Bhalla and co-workers have modeled various
cascade interactions that may be involved in
long-term potentiation in neurons and
maintaining memory. Their work included
biologically realistic kinetic models of these
processes that capture the emergence of
altered cellular characteristics arising from
particular pulse trains at the cell surface
(Bhalla and Iyengar 1999). Their model
structures and other efforts to create virtual
cells should aid in providing the biological
detail for realistic BBDR models for various
signaling motifs. 
Glycoprotein-stimulating hormonessuch
as thyroid-stimulating hormone, follicle-
stimulating hormone (FSH), and luteinizing
hormone are released by the pituitary and
have end-organ effects on endocrine tissues.
These hormones cause cellular responses by
binding to cell-surface G-protein–coupled
receptors. Binding leads to activation of
adenylate cyclase (AC), with production of
cyclic adenosine monophosphate (cAMP).
Phthalate esters interfere with FSH-mediated
signaling in Sertoli cells (Heindel and Chapin
1989), although the exact sites of interaction
remain uncertain. The responses of various
endocrine tissues to these hormones depend
on cAMP and on a variety of other signaling
molecules in the cell (Richards 2001), includ-
ing inducible kinases and guanosine triphos-
phatases. The efforts to unravel these
signaling pathways should lead to a represen-
tation of the key functional elements
involved in G-protein–coupled signaling in
these cells and an improved understanding of
the role of these cascades in toxicity, disease,
and health. 
Generic tools. New methods for model-
ing the control of gene batteries in normal
systems may use Boolean networks
(Kaufman 1995) or apply neural network
models (Vohradsky 2001) for expression of
multiple gene families. Quantum computa-
tional or predictive structural activity rela-
tionship approaches, such as the reaction
network modeling approach being devel-
oped in our laboratory (Liao et al. 2002),
should facilitate the simulation of molecular
circuits and cellular switches. The contri-
butions from groups developing more quan-
titative tools to assess physiological
coordination of multiple cellular activities,
e.g., the Physiome Project (Physiome 2002),
may significantly expand the mathematical
dose–response modeling approaches used by
toxicologists and risk assessors for integrat-
ing the exposure–response–dose paradigm
into a perturbation paradigm assessing toxic
potential of compounds. Programming tools
for modeling neuronal function (Genesis
2002; Wilson et al. 1989) or the entire cell
(Tomita et al. 1999) are also available for
evaluating integrated signaling motifs.
Although there are many candidate tools for
developing models of genetic circuitry, the
immediate future in this area will require
trial and error to discern the mathematic/
simulation tools that will allow the most
rapid progress. A brief synopsis of some of
the major signaling motifs and several avail-
able tools for analysis of biological circuits is
listed in Table 1.
Systems theory. Increasingly, integrative
biological research relies on systems theory
for connecting biological experiments with
computational descriptions of cellular struc-
ture and dynamics. Systems theory, i.e., the
study of systems that are conceptualized
using networks to deﬁne information ﬂows,
uses engineering concepts such as robust-
ness, fragility, and failure cascades (Csete
and Doyle 2002) and serves as an organiza-
tional scaffold to support complex system
modeling. Current interest in systems biol-
ogy is partly an outgrowth of the need to
conceptualize, hypothesize, modularize,
design experiments, communicate ideas,
and share results between research institu-
tions. It is also partly a result of the need to
integrate new computational methods, to
construct and interface complex models
from different sources and disciplines, and
to integrate diverse information from
genomics, proteomics, and metabonomics
into coherent models readily shared among
different research groups. Bifurcation theory
(Tyson et al. 2001) may serve as a computa-
tional aid to identify attractors, even though
the parameter space for the individual com-
ponents of the biological system becomes
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Table 1. Some signaling motifs and possible analysis tool.
Motif or tool Mechanism Reference
Empirical transcriptional Enzyme induction, receptor binding Kohn et al. 1993
activation models and transcriptional upregulatory Andersen et al. 1997a,b
mechanisms
Steroid hormones Vitellogenesis Shapiro et al. 1989
Tata et al. 1993
Oocyte maturation Ferrell and Machleder 1998
Early/late responses Landers and Spelsberg 1992
Schuchard et al. 1993
Peptide hormones FSH-and G-protein–coupled surface Clement et al. 2001
receptors
Cell cycle Positive feedback in protein regulation Tyson et al. 2001
through phosphorylation and related
control mechanisms
Cell cycle map  Kohn 1999
DNA methylation Transcriptional regulation through Xu et al. 2001
histone modiﬁcation
Cellular signaling Alliance for cellular signaling AFCS 2002
Stochastic processes Two-stage tumorogenesis Moolgavkar and Knudson 1981
Two-stage growth model for  Conolly and Kimbell 1994
precancerous lesions and tumors
Neuronal function Genesis Genesis 2002
Systems biology Systems Biology Markup Language Systems Biology 2002
Modeling tools Berkeley Madonna Macey and Oster 2002
Advanced Continuous Simulation  ACSL 2002
Language (ACSL)
MatLab MathWorks 2002
Scope SCoP 2002
BioSpice (under development) Biospice 2002very large. This approach examines the
effects of parameter variation on solutions
of the nonlinear circuit model. 
Rapid progress applying systems biology
is apparent in a number of research fields,
including immune function (Germain
2001), the cardiac system (Noble 2002),
developmental biology (Davidson et al.
2002), and prokaryotic systems (Kitano
2002; Weng et al. 1999). Eventually,
BBDR models for alterations in signaling
motifs and nonlinear toxicological responses
may be linked to organ system descriptions
of physiology to predict both early responses
(i.e., activation or deactivation of biological
switches regulating signaling motifs) and
adverse responses (i.e., diminished physio-
logical function or diminished adaptability
to stress). Such models would fulfill the
goals proposed by Noble of having tools to
simulate expected results, aid in experimen-
tal design, and predict biological/toxicologi-
cal consequences throughout the full range
of exposure situations with environmental
toxicants (Noble 2002). 
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